OTISNEUTRAL

OTIS P/E Ratio Analysis

18.3x

Updated 1467h ago·SEC filings & market data

Key Takeaway

The P/E ratio of 18.3x compares a stock’s price to its earnings per share, showing how much investors pay for each dollar of profit.

Sector Performance

35th percentile

OTIS

18.3x

Sector Median

22.9x

Sector Avg

34.3x

Prior Period

18.9x(Jul 2026)

↑ Improving
📊

Deep Analysis

The P/E ratio of 18.3x compares a stock’s price to its earnings per share, showing how much investors pay for each dollar of profit.

At 18.3x, OTIS is cheaper than the sector median of 23.4x, sitting in the 34th percentile among peers, meaning about two-thirds of comparable stocks trade at higher multiples. The trend data is N/A, with no year-over-year change and no quarter-over-quarter change available, so no momentum can be inferred from this metric. Because the valuation is below the sector norm but lacking any trend direction, the risk appears moderate — there is no signal that the discount is widening or closing. This level alone does not indicate a clear opportunity, but it also does not point to overvaluation. This metric supports the overall NEUTRAL verdict, as the below-median multiple is offset by the absence of trend information.

Frequently Asked Questions

What does the P/E Ratio tell investors about OTIS?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master OTIS's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full OTIS research report →

Free account — no credit card

OTIS

18.3x

Sector Median

22.9x

Sector Avg

34.3x

How OTIS's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.